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The design of a drug delivery system capable of a pH-responsive controlled 5-ﬂuorouracil anticancer drug release
to cancer sites is one of the important options to reduce the well documented side eﬀects of this drug.
La0.7Sr0.3MnO3 (LSMO) magnetic nanoparticles (MNPs) were synthesized by solution combustion synthesis and
the optimized MNPs were coated with silica. X-ray diﬀraction patterns reveal that the crystal structure is a single
perovskite phase which was unchanged after silica coating. Silica coating on LSMO was found to reduce the
nanoparticle crystallite and magnetic properties. The silica surface of LSMO MNPs was functionalized to confer a
pH-dependent switchable surface and was used to demonstrate the pH-responsive controlled release of 5-FU
anticancer drug which was signiﬁcantly higher than the 5-FU released from silica coated LSMO MNPs that were
not functionalized. The in-vitro release studies show that only 11.36% of 5-FU was released at pH 7.4 (mimic of
the physiological environment) and 37.20% at pH 5.0 (mimic of the intracellular organelles of cancer cells). The
pH-responsive release of this functionalized silica coated LSMO MNPs suggest that it could be used in the
controlled release of 5-FU anticancer drug at tumor sites.
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1. Introduction
Many anticancer drugs exhibit poor aqueous solubility, low bioa-
vailability, low selectivity and non-speciﬁcity which often limit their
clinical use. As a result, research has been focused on the development
of drug delivery systems (DDS) capable of not only a sustained and a
controlled release of its cargo at diseased sites but also incorporating a
targeting moiety. Such additional functionalities in a DDS will enhance
the eﬃcacy of anticancer drugs and reduce their associated side eﬀects.
DDS can use the passive and active targeting mechanisms to deliver
their cargoes to diseased sites. Magnetic nanoparticle-based anticancer
DDS, for example, are accumulated and retained in the cancerous ex-
tracellular matrix through leaky blood vessels at the cancer sites, the so
called enhanced permeation retention eﬀect. After systemic adminis-
tration and increased half-life in the blood circulation, well-deﬁned
magnetic nanoparticle-based DDS can reach and be retained in the
cancer sites also beneﬁting from the passive targeting eﬀect [1,2]. To
further improve drug delivery to cancerous site and invariably reduce
side eﬀects, smart nano-vectors are being developed capable of charge
reversal in response to external stimuli such as pH [3–5] for the con-
trolled release of their payloads at cancerous site (active targeting ef-
fect).
Amongst the common drug solubilisation strategies used in the
pharmaceutical industry, nano-delivery systems have been the most
promising [6]. In this regard, magnetic nanoparticles (MNPs) have at-
tracted great interest due to their inherent magnetic properties and
biocompatibility [7]. The use of MNPs in targeted drug delivery trig-
gered by pH change and magnetic activation has been demonstrated
[3,8–10]. The unique physico-chemical properties of MNPs coupled
with their sensing, moving and heating capabilities have made them to
be amenable in biomedical applications such as targeted drug delivery,
magnetofection, hyperthermia, etc. Naturally, superparamagnetic iron
oxides nanoparticles have been the most popular formulations used in
biomedical applications because of its ease of synthesis, high bio-
compatibility and easy functionalization. However, there has been an
increasing interest in the use of lanthanum manganese perovskite
(LSMO) materials for biomedical applications due to their tunable Curie
temperature, biocompatibility and superparamagnetic nature [11].
5-ﬂuorouracil (5-FU) is an eﬀective anticancer drug available for the
treatment of a variety of solid cancers such as stomach, colon, lung and
breast cancer [12–15]. 5-FU is usually given intravenously because of
the problems associated with its oral administration. The intravenous
route of administration is associated with problems such as toxic side
eﬀects on the bone marrow and gastrointestinal tract and its low se-
lectivity [16,17]. Also, 5-FU is sparingly soluble in water [18]. In order
to overcome these limitations, nanoparticle based stimuli responsive
delivery systems are being exploited for the controlled release of 5-FU
to cancerous site.
Herein, we report the development of a pH responsive functiona-
lized silica coated MNPs that is capable of triggered intracellular 5-FU
release as a result of charge reversal at the lower pH in cancer cells to
enhance the release of 5-FU drug. Porous silica was chosen for the
surface modiﬁcation of the LSMO MNPs because of their large, easily
tunable surface and biocompatibility. The silica surface was covalently
functionalized with (3-Amino propyl)triethoxysilane to confer a charge
reversal (switchable surface) in response to pH. The silanol groups
would be ionized, at pH 7.4 (physiological environment), to be more
negatively charged which aids the increased entrapment of positively
charged 5-FU drug. While at pH 5 (intracellular organelles of cancer
cells) there is a charge conversion due to increased protonation of the
amine groups and diminished silanol ionization thereby, facilitating the
escape of the entrapped 5-FU drug at cancerous site where its activity is
needed.
2. Experimental
2.1. Materials
All chemical reagents namely lanthanum nitrate, strontium nitrate,
manganese nitrate, citric acid monohydrate, tetraethoxy silane (TEOS),
ethanol, ammonia solution (ammonium hydroxide solution, ca 25%
NH3) and (3-Amino propyl)triethoxysilane (APTES) were obtained from
Sigma Aldrich. 5-Fluorouracil was obtained from Alfa Aesar, UK.
Double distilled water was used throughout the experiments. All the
solvents and other materials used were of analytical grade and were
used without further puriﬁcation.
2.2. Synthesis of LSMO cores
La0.7Sr0.3MnO3 (LSMO) MNPs were prepared by the solution com-
bustion method using citric acid as fuel. The optimization of the particle
size, crystallinity and magnetisation of LSMO MNPs using diﬀerent ci-
tric acid to nitrate ratios have been reported elsewhere [19]. The fuel
rich LSMO sample was selected since it presented a pure LSMO phase
and a comparatively high saturation magnetization.
2.3. Surface coatings of LSMO MNPs
The following LSMO MNPs were coated with silica by the modiﬁed
Stober method [20]. The dried MNPs (100 mg) were added to ethanol
solution (150 mL) that had distilled water (10 mL) and ammonium
hydroxide (2 mL) and the solution was sonicated for 1 h. Then, TEOS
(2 mL) was added to the solution and sonicated for 15 min with this
process repeated twice. Finally, the mixture was allowed to stand for
24 h. The solution was ﬁltered and the MNPs were washed with ethanol
ﬁve times and dried at 60 °C in the oven to obtain LSMO-SiO2.
2.4. APTES functionalisation of LSMO-SiO2
The functionalization of LSMO-SiO2 with APTES was done ac-
cording to the method described elsewhere [21]. LSMO-SiO2 (30 mg)
was dispersed in acetonitrile by sonication. 100 μL APTES was added to
the dispersion and was reﬂuxed at 85 °C for 24 h to yield aminopropyl
functionalized silica coated LSMO MNPs. The precipitate was then
centrifuged and washed once with acetonitrile and thrice with hot
methanol (40 °C) before drying it at 60 °C for 45 mins to obtain LSMO-
SiO2-NH2.
2.5. 5-FU loading and release studies
5-FU stock solution (0.2 mg/ml) was prepared in 0.1 M PBS buﬀer
of pH 7.4. Accurately weighed LSMO-SiO2-NH2 (1 mg) MNPs were
dispersed in 5-FU stock solution (1 mL). The dispersion was stirred for
12 h in the dark using a bath sonicator. After loading, LSMO-SiO2-NH2
MNPs were washed twice with PBS buﬀer (pH 7.4). All washings were
collected and the amount of 5-FU were quantiﬁed from UV–vis ab-
sorption at 266 nm [21,22]. To measure the amount of 5-FU loaded,
calibration curves were done at pH 7.4. The entrapment eﬃciency (EE)
was calculated as follows (Eq. 1). Same procedure was followed for the
5-FU loading of LSMO-SiO2.
=
− −
−
×EE amount ofdrug loaded in LSMO SiO NH
Total charged amount of FU
(%) 2 2
5
100
(1)
To study the controlled release of 5-FU from the loaded MNPs, 1 mg
of 5-FU loaded LSMO-SiO2-NH2 MNPs was dispersed in 1 mL of 0.1 M
PBS buﬀer (pH 7.4 and pH 5.0) using a bath sonicator. At 4 h intervals,
the released amounts of 5-FU were determined by recording the ab-
sorbance of 500 μL aliquots of supernatant taken using UV–vis spec-
troscopy with the withdrawn aliquot added to the test tube. All the
release studies were performed at room temperature. Same procedure
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was followed for the release studies of 5-FU loaded LSMO-SiO2.
2.6. Characterisation
XRD was used to identify the structure and phase of the nano-
particles. The X-ray diﬀractograms of the annealed powders were done
at room temperature using a D8 Advance Bruker diﬀractometer with
Cu-Kα radiation source at λ= 0.15406 nm in the 2θ scan range be-
tween 10° and 80° at 40 kV, 40 Ma. The X-ray line broadening dif-
fraction peak (110) was employed to calculate the mean crystallite size
(D) of the MNPs using the Scherrer formula:
=D λ
βCosθ
0.9
where β is equal to the spectral breadth of the line broadening of the
(110) peak measured at half of the height of the peak, θ is the Bragg
angle and λ is the radiation wavelength of X-ray used. The surface
morphological images and elemental composition of the synthesized
NPs were obtained using ﬁeld emission scanning Electron Microscopes
(Nova Nano SEM 600, FEI Co., Netherlands). The silica coating was
investigated by using Fourier Transform Infrared spectroscopy (ALPHA,
Bruker) in the range of 400–4000 cm−1. Magnetic measurements of the
bare and silica coated MNPs were done at room temperature using a
Vibrating Scanning Magnetometer (Lake Shore cryotronics-7400
series). Colloidal stability studies of the uncoated and silica coated
MNPs in water and in PBS were done using a zetasizer Nano Zs
(Malvern instruments). Triple measurements of each sample were done
for the Zeta potential at 30 electrode cycles.
3. Results and discussion
3.1. Coating of LSMO MNPs with silica and aminopropyl functionalisation
of LSMO-SiO2
Silica was selected for the coating of LSMO MNPs because unlike
polymers, it does not change porosity or swelling in relation to pH
changes and it is not susceptible to microbial attack [23]. Also, silica
coatings on nanoparticles provide a rich surface chemistry, high bio-
compatibility and an anomalously high stability, especially in aqueous
media. The silica surface (LSMO-SiO2) was covalently functionalized
with APTES to confer charge reversal on the MNPs to yield LSMO-SiO2-
NH2. The schematic of the silica coating of LSMO MNPs and the
aminopropyl functionalisation of the silica surface is shown in Fig. 1.
3.2. X-ray diﬀractometry of silica coated LSMO MNPs
XRD was performed on the silica coated sample of nanocrystalline
LSMO powder and the diﬀraction pattern is shown in Fig. 2. The dif-
fraction peaks of the silica coated sample, like the uncoated sample,
gave characteristic peaks of rhombohedral perovskite structure R-3c
(167) space group. The results showed that the silica coated sample
retained the perovskite structure but with a slight suppression of dif-
fraction peaks. Therefore, the XRD data suggests that the silica shell
consists mainly of amorphous phase rather than polycrystalline one
[24] since there is the absence of silica-derived diﬀraction peaks.
The crystallite size obtained for the silica coated sample (35 nm)
was slightly lower than the uncoated sample (36 nm). A reduction in
crystallite size was also recorded for silica coated CoFe2O4 [25]. This
reduction might be due to a lesser agglomeration due to silica coating.
The diﬀraction peaks of all the samples were quite broad, indicating
their nanocrystallinity.
Fig. 1. Schematic of silica coating of LSMO MNPs and ami-
nopropyl functionalization of LSMO-SiO2.
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Fig. 2. XRD of (a) uncoated and (b) silica coated nanocrystalline LSMO powders.
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3.3. Morphological and chemical composition analysis of silica coated
LSMO sample
The FE-SEM images of uncoated and silica coated LSMO MNPs is
given in Fig. 3a–b, respectively. There is a reduction in the particle
agglomeration as seen in the image of the coated sample in relation to
the uncoated sample. The reduced agglomeration conﬁrms the presence
of silica coating on the MNPs which helps to reduce the magnetic in-
teractions between NPs and gives a fair homogeneous particle size
distribution. The MNPs after silica coatings gives a core-shell like
conﬁguration with LSMO MNPs as the core and the silica as the shell
(indicated as lighter contours enveloping the MNPs). It can be seen that
the LSMO particles were coated with silica. Silica coating of LSMO aids
in preventing antigenical eﬀects which could occur as a result of the
potential recognition of LSMO surfaces by macrophages that clears the
particles from the system, thereby preventing the MNPs from reaching
the tumour sites [22].
3.4. Magnetic studies of silica coated LSMO sample
The magnetization loops of the uncoated and silica coated LSMO
samples measured at room temperature are shown in Fig. 4. The
magnetic parameters including the saturation magnetisation (Ms),
remnant magnetization (Mr), coercivity (Hc) and squareness of the loop
(Mr/Ms) of the uncoated and coated sample have been extracted from
the magnetization loop and are given in Table 1. It can be seen that the
applied magnetic ﬁeld of 20, 000 G was not suﬃcient to saturate the
magnetic moments in the coated sample in its direction, like the un-
coated sample. The saturation magnetization of the coated sample
(7 emu/g) is smaller compared to the uncoated sample (11 emu/g). The
presence of silica coatings that is non-magnetic might account for the
reduction in magnetization seen in the coated sample. The silica coat-
ings help to reduce the energy associated with exchange coupling and
the particle–particle interaction and therefore reduc the magnetization
[26]. The reduction in magnetization might also be due to the lesser
amount of magnetic substance per gram in the silica coated sample
compared with the uncoated sample [27]. Lesser Mr and Mr/Ms values
were recorded for the coated sample but a higher Hc values than the
uncoated sample. Very low Mr and Hc were recorded for both the un-
coated and coated samples highlighting their near superparamagnetic
nature. The silica coated LSMO MNPs gave a saturation magnetization
that is required for biomedical applications which should be at least
7–27 emu/g [3].
3.5. Infrared analysis of silica coated LSMO (LSMO-SiO2) and
aminopropyl functionalisation of LSMO-SiO2 (LSMO-SiO2-NH2) samples
The FTIR spectra of uncoated, LSMOeSiO2 and LSMOeSiO2eNH2
samples are shown in Fig. 5a–c, respectively. In the uncoated sample
(Fig. 5a), the band around 578 cm−1 corresponds to MneO vibrations
characteristic of perovskite structure [28]. The spectra of carbon asso-
ciated functional groups, particularly carboxyl groups, appear in
1000–2500 cm−1 region [29]. These bands might be due to traces of
the unburnt fuel (citric acid) used in the synthesis of the sample. It has
been reported that higher temperatures than 1000 °C are required to
remove all these carbons associated with the synthesis of LSMO MNPs
[30]. Free carbon or carbonates can result from the degradation of ci-
trates if lower calcination temperature is employed. The peaks at
1450 cm−1 and 2337 cm−1 are due to C]O vibrations which can be
related to traces of carbonate [29]. The two peaks at 850 cm−1 and
1450 cm−1 are due to SrCO3 [29]. The peak at 1450 cm−1 is due to
CeO bond asymmetric stretching mode while the peak at 850 cm−1
corresponds to the in plane bending CO32−.
In the case of LSMO-SiO2, the FTIR spectrum (Fig. 5b) shows all the
signiﬁcant vibrations relevant to silica. Vibrations at 449 cm−1 and
1075 cm−1 correspond to Si-O-Si bending and stretching, respectively
[31,32]. The band at 946 cm−1 can be assigned to silanol groups [33]
while the one at 798 cm−1 is due to SieOeSi bending vibrations
[34,35]. It can be seen that the MneO vibrations observed at 578 cm−1
in the uncoated sample, appeared at 569 cm−1 indicate the presence of
the perovskite structure and silica coatings. In the case of the FTIR
Fig. 3. FESEM images of LSMO powders (a) uncoated (b) silica coated.
Fig. 4. Magnetic loops of LSMO for (a) the uncoated sample (b) silica coated sample.
Table 1
Magnetic Properties of Silica Coated LSMO MNPs.
Sample Saturation
Magnetisation, Ms
(emu/g)
Remanence
Magnetisation, Mr
(emu/g)
Coercivity
(Gauss)
Mr/Ms
Uncoated
sample
11 4.20 34 0.38
Silica coated
sample
7 1 37 0.14
C.O. Ehi-Eromosele et al. Colloids and Surfaces A 530 (2017) 164–171
167
spectrum of LSMOeSiO2eNH2 (Fig. 5c), vibrations at 677 cm−1 and
1496 cm−1 are due to the amino groups stretching and bending vi-
brations. The absorption peaks in the region of 2800–3025 cm−1 can be
assigned to the stretching vibrations of methylene groups at LSMOe-
SiO2eNH2. The absorption peak at 1201 cm−1 corresponds to the
symmetric deformation vibrations of SiCH3. This peak is missing for
LSMOeSiO2, conﬁrming the incorporation of amino-propyl to silica
surface.
3.6. Zeta potential studies of LSMO-SiO2 and LSMO-SiO2-NH2
The pH dependent zeta potential of LSMO-SiO2 and LSMO-SiO2-NH2
samples is shown in Fig. 6. The zeta potential distribution of uncoated,
LSMO-SiO2 and LSMO-SiO2-NH2 samples using distilled water as a
dispersant were 2.4 mV, −7.45 mV and 7.82 mV, respectively. In
aqueous environment, the silanol groups ionize to become negatively
charged [36] while LSMO-SiO2-NH2 will become positively charged as
a result of protonation. The uncoated sample showed a lesser zeta po-
tential (2.4 mV) than the coated sample (−7.45 mV) indicating a lesser
aggregation of the coated samples in water when compared with the
uncoated sample. It is known that colloidal stability increases with in-
creasing zeta potential values. Fig. 6 shows that LSMO-SiO2-NH2
sample exhibited charge reversal with respect to pH. At pH 7.4, it shows
a negative potential of −12.2 mV which changed to a positive value
(+18.9 mV) at pH 5. On the other hand, zeta potential shows no charge
reversal for LSMO-SiO2. It shows a change only in the negative regime
from −19.4 mV at pH 7.4 to −6.92 mV at pH 5. As it has been stated
earlier, the negative charge comes from the ionization of the silanol
groups [36]. At a pH of 7.4, there would be an increase in the ionization
of the silanol groups resulting in increased negative charges in the
sample. At pH 5, the silanol ionization is lesser thus lowering the net
negative charge. At pH 7.4, the surface of LSMO-SiO2-NH2 is less ne-
gative (−12.2 mV) than that of LSMO-SiO2 (−19.4 mV). As the pH is
reduced to 5, the surface becomes positive (+18.9 mV) due to in-
creased protonation of the amine groups and decreasing silanol ioni-
sation. The colloidal stability is also enhanced at pH 5 indicating its
potential to be used as a vector in a drug delivery system. The existence
of the acidic environment (pH 6) at the cancerous extracellular matrix
would help LSMO-SiO2-NH2 to acquire positive charge which is essen-
tial for its cellular entry through electrostatic interactions with nega-
tively charged cell wall. Inside the cell, the endosomal pH is even more
acidic (pH 5) which makes LSMO-SiO2-NH2 MNPs more positive [21].
Acquisition of strong positive charge by LSMO-SiO2-NH2 MNPs is ex-
pected to facilitate the release of positively charged anti-cancer drugs
such as 5-FU.
3.7. 5-FU loading and release studies
Drug loading and release behaviour are the most important char-
acteristics when evaluating a drug delivery system [37]. Fig. 7 gives the
schematic diagram of the drug loading and release of LSMO-SiO2-NH2
MNPs. An anticancer drug (5-FU) was loaded onto the LSMO-SiO2-NH2
MNPs and was held electrostatically. Loading of 5-FU was done at pH
7.4 and at room temperature. At this pH, LSMO-SiO2-NH2 is negatively
charged (−12.20 mV) and 5-FU is positively charged (pKa∼8) leading
to high entrapment eﬃciency of ∼88%. 5-FU pH dependent release
proﬁle was studied by incubating the 5-FU loaded LSMO-SiO2-NH2
MNPs for 24 h at room temperature. Fig. 8 shows the 5-FU release
Fig. 5. FTIR spectra of (a) uncoated LSMO (b) LSMO-SiO2 (c) LSMO-SiO2-NH2.
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Fig. 6. Zeta potential dependence of pH for LSMO-SiO2 and LSMO-
SiO2-NH2 samples.
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proﬁle at pH 5.0 and 7.4. A high release of 5-FU (37.20% in 24 h) is
shown by LSMO-SiO2-NH2 at pH 5.0 (endosomal pH) due to the re-
pulsive interaction between the positively charged drug and positive
LSMO-SiO2-NH2 (+18.90 mV). In normal extracellular pH (i.e. 7.4), a
low release (11.36%) was observed due to the electrostatic interaction
between the positively charged drug and negatively charged LSMO-
SiO2-NH2. The results clearly show that the release of 5-FU from 5-FU
loaded LSMO-SiO2-NH2 MNPs is pH-triggered.
The release studies of 5-FU from LSMO-SiO2 was done to compare
its eﬃcacy with that of LSMO-SiO2-NH2, and the result is given in
Fig. 9. 5-FU was loaded to LSMO-SiO2 at pH 7.4 with an entrapment
eﬃciency of 92%. The increase in entrapment eﬃciency, compared to
LSMO-SiO2-NH2, might be due to the higher electrostatic attraction
between the drug and LSMO-SiO2 having a higher negative charge of
−19.40 mV. Release proﬁle for LSMO-SiO2 showed that maximum re-
lease of 5-FU was at pH 5.0 which is about 13.20% after 24 h while a
maximum release “of 6.20%” was observed at pH 7.4. The release
proﬁle is consistent with the zeta potential values where LSMO-SiO2 at
pH 5 (−6.92 mV) is expected to be less bound to 5-FU than at pH 7.4
(−19.40 mV) hence recording a higher release of 5-FU. Conversely,
LSMO-SiO2 recorded a lesser release of 5-FU at both pH values than
LSMO-SiO2-NH2. At pH 7.4, LSMO-SiO2 recorded a higher negative
potential making it more bound to 5-FU electrostatically. At pH 5.0,
LSMO-SiO2-NH2 recorded a higher release of 5-FU than LSMO-SiO2
because of the charge reversal that released 5-FU by electrostatic re-
pulsion. The high entrapment eﬃciency and the pH-sensitive release of
5-FU imply that LSMO-SiO2-NH2 is a potential delivery system for 5-FU
anticancer drug. To our knowledge, there is no report in the literature
that has dealt with the use of LSMO MNPs as a delivery vehicle for 5-FU
anticancer drug. Table 2 summarises the surface charges, entrapment
eﬃciency and 5-FU releases at diﬀerent pH for LSMO-SiO2-NH2 and
LSMO-SiO2.
The calibration curve made from known concentrations of 5-FU was
used to calculate the amount of 5-FU released. Fig. 10 shows a UV–vis
spectra of the 5-FU in calibration solutions and Fig. 11 shows the ca-
libration curve for 5-FU.
4. Conclusion
La0.7Sr0.3MnO3 (LSMO) MNPs were synthesized by the solution
combustion synthesis and the optimized MNPs were coated with silica
which was subsequently used as a drug delivery system. Silica coatings
with improved surface area and high speciﬁc volume were utilized for
the loading of 5-FU. Furthermore, silica surface of LSMO MNPs was
functionalized with APTES which conferred a switchable surface in
response to pH which was not observed with the silica coated LSMO
MNPs. The charge reversal of the designed system from negative to
positive as pH varied from 7.4 to 5.0 was used for the eﬀective release
of the loaded 5-FU anticancer drug at endosomal pH 5.0. The high
entrapment eﬃciency and the pH-sensitive release of 5-FU imply that
LSMO-SiO2-NH2 could be employed as a promising controlled 5-FU
drug delivery system thereby helping to reduce the well documented
side eﬀects of this drug. However, further work needs to be done
Fig. 7. Schematic of 5-FU drug loading and release of LSMO-SiO2-NH2
MNPs.
4 8 12 16 20 24
5
10
15
20
25
30
35
40  pH 7.4
 pH 5.0
Fig. 8. 5-FU release proﬁles from LSMO-SiO2-NH2 at diﬀerent pHs.
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concerning the drug release studies to clarify the eﬀects of ionic
strength, types of ions, proteins, metabolites and other molecules before
it can be fully implemented in physiological environment.
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